PATENT CLAIM ANALYSIS

Application Number: 16006210
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
Provided herein are methods for the purification of recombinant adeno-associated virus (rAAV) vectors that can be used for gene transfer and specifically for gene therapy or vaccination. Recombinant AAV vectors of the invention are substantially free of in-process impurities, including production components such as cellular nucleic acids, cellular proteins, helper virus, and media components.

Claim (Index 44):
The method of  claim 1 , further comprising a step of subjecting the feedstream containing the rAAV particles to tangential flow filtration (TFF) prior to contacting the feedstream containing the rAAV particles with the apatite chromatography medium.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 94.0
- Lexical Diversity: 1.34783
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13328306', '10016767', '15350409', '10020482', '10851688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.721827082827245
- 35 USC 102 Novelty (BERT): 0.6186387627171444
- Combined Prediction Score: 0.7115082508162349
- Mean Citation Score: 321.508458
- Max Citation Score: 662.2674599999998
- Similarity Product: 488.7748038741874

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test